JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist
  • 203
  • -14-6.45%
20min DelayMarket Closed Jul 12 15:00 JST
8.79BMarket Cap-7449P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Noile-Immune Biotech Earnings Date

Currency: JPY

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

2.59M

-68.07%
EPS(YoY)

-7.86

+37.07%
Analyst Rating

Strong Buy

Dec 19, 2023

Noile-Immune Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 14, 20242024/Q12.000M / ----
Nov 13, 20232023/Q3303.000M / ----
DatePeriodRevenue/EstimateEarnings Call
May 14, 20242024/Q12.000M / ----
Nov 13, 20232023/Q3303.000M / ----
--------
--------
--------

Unlock Free Earnings Estimates

Noile-Immune Biotech Earnings Reports

  • Noile-Immune Biotech: Confirmation letter

    May 14 04:07 ET

  • Noile-Immune Biotech: Quarterly Report - 10th Quarter 1st Quarter (2024/01/01 - 2024/03/31)

    May 14 04:05 ET

  • Noile-Immune Biotech: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

    May 14 04:00 ET

  • Neurimune Biotech: Extraordinary Report

    Apr 2 00:49 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 19, 2023

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg